No Data
No Data
No Data
No Data
No Data
Pharming Group's Strategic Financial Maneuver
TipRanksApr 26 00:02
Pharming Group Lauded for Rare Disease Treatment
TipRanksApr 24 18:59
Pharming Group to Report First Quarter 2024 Financial Results on May 8
Yahoo FinanceApr 24 14:00
Pharming to Be Honored as Industry Innovator at National Organization for Rare Disorders (NORD) 2024 Rare Impact Awards
Recognition given for achievement in commercializing Joenja (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands, April
GlobeNewswireApr 24 13:00
Pharming Group to Buy Back EUR123 Million of Bonds Due 2025
Pharming Group (PHARM.AS) accepted 123.1 million euros of its outstanding 125 million euros of 3% senior unsecured convertible bonds due 2025 for repurchase. The Dutch biopharmaceutical company said A
MT NewswiresApr 22 13:15
Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds
Pharming Group (PHARM.AS) on Thursday launched an offering of 100 million euros of senior unsecured convertible bonds due 2029 and a repurchase offer for its outstanding 125 million euros of convertib
MT NewswiresApr 18 16:52
No Data
No Data